Throughout the global Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) trials, compared to all the other comparators once-weekly semaglutide displayed greater short-term efficacy, with more significant reductions in HbA 1c and multiple cardiometabolic benefits (including improving the control of blood pressure, blood lipids and body weight, among others) [14,15,16,17,18,19,20,21,22]
Where is it registered
Lancet 366(9491):10591062
If symptoms persist, discuss dose adjustment options with your healthcare provider
The key is choosing a copper peptide formulation with proven bioactive ingredients and applying it after scalp stimulation to maximise absorption